2 weeks Ago
Omeros Corporation ( NASDAQ: OMER ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Jennifer Cook Williams - Investor and Media relations, Cook Williams Communications, Inc. Gregory Demopulos - Chairman and Chief Executive Officer David Borges - Chief Accounting Officer Andreas Grauer - Chief Medical Officer Steven Whitaker - Vice President, Clinical Development Conference Call Participants Steve Brozak - WBB Olivia Brayer - Cantor Fitzgerald Serge Belanger - Needham & Company Operator Good afternoon, and welcome to today's conference call for Omeros Corporation. At this time, all participants are in a listen-only mode.
After the company's remarks, we will conduct a question-and-answer session. [Operator Instructions]. Please be advised that this call is being recorded at the company's request and a replay will be available on the company's website for one week from today.
I will now turn the call to Jennifer Williams, Investor Relations for Omeros. Jennifer Cook Williams Good afternoon, and thank you for joining the call today. I'd like to remind you that some of the statements that will be made on the call today will be forward-looking.
These statements are based on management's beliefs and expectations as of today only and are subject to change. All forward-looking statements involve risks and uncertainties that could cause the company's actual results to differ materially. Please refer to the special note regarding forward-looking statements in the company's quarterly report on Form 10-Q, which was filed today with the SEC, and the Risk Factors section of the company's most recent annual report on Form 10-K and its subsequently filed quarterly reports for a discussion of these risks and uncertainties.
Now I would like to turn the call over to Dr. Greg Demopulos, Chairman and CEO of Omeros. Gregory Demopulos Thank you, Jennifer, and good afternoon, everyone.
I'm joined on today's call by our.
